Ajooni Biotech Ltd Stock Price Today (NSE: AJOONI)

Ajooni Biotech Ltd

3.81+0.01 (+0.26%)
Market Closed

Fundamental Score

...

Ajooni Biotech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Ajooni Biotech Ltd share price today is 3.81, up +0.26% on NSE/BSE as of 17 June 2026. Ajooni Biotech Ltd (AJOONI) is a Small-cap company in the Animal Feed sector with a market capitalisation of 81.64 (Cr). The 52-week high for AJOONI share price is 6.60 and the 52-week low is 3.55. At a P/E ratio of 20.51x, AJOONI is currently trading above its industry average P/E of 18.96x. The company has a Return on Equity (ROE) of 5.15% and a debt-to-equity ratio of 0.10.

Ajooni Biotech Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
4.42
Low
3.81
Volume
2.6L
Change
+0.47%

Ajooni Biotech Ltd share price chart: 0.47% return over the past month. 52-week high ₹6.60, 52-week low ₹3.55.

Ajooni Biotech Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
4.014.164.004.014.44L (Cr)
4.184.184.024.074.68L (Cr)
4.254.254.124.154.04L (Cr)
4.274.284.234.261.61L (Cr)
4.244.304.184.252.96L (Cr)
4.164.234.124.222.30L (Cr)
4.084.164.084.131.14L (Cr)
4.164.194.104.102.93L (Cr)
4.134.174.114.162.35L (Cr)
4.114.194.084.172.01L (Cr)

Ajooni Biotech Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
4.184.184.004.01-4.07%
4.304.424.024.15-3.49%
3.884.503.884.20+8.25%
4.244.753.673.84-9.43%
4.655.504.144.43-4.73%
4.404.403.553.89-11.59%
4.784.894.174.31-9.83%
5.155.324.164.83-6.21%
5.275.295.055.17-1.90%
5.405.945.075.27-2.41%
5.505.945.015.39-2.00%
6.056.155.255.43-10.25%

AI Research Briefing

Powered by Gemini · 2026-04-17

Microcap animal feed company with wafer-thin margins and execution risk.

Research Confidence
5.0/10Moderate
MICRO-CAP DARK HORSE1M: -8.32% | 3M: -9.71% | 6M: -18.56%. Downtrend [cite:]P/E of 20.51x vs Industry P/E of 18.96x. Slightly expensive [cite:]

WHAT'S HAPPENING NOW (last 2-4 weeks)

No major catalysts found after live search.

CORE STORY (THE REAL GAME)

Commoditized animal feed play. Ajooni is trying to scale in a fragmented market, but lacks a real moat. It's a volume game with low margins.

Why Now
  • ₹47.52 crore order win
  • New plant commissioned
  • Animal feed market growing at 6.6% CAGR
Potential Catalysts
  • Consistent order flow
  • Raw material cost stabilization
  • Successful capacity utilization
Key Risks
  • Microcap liquidity risk
  • Negative free cash flow [cite:]
  • Low promoter holding at 26.89%
Institutional Activity

No FII/DII interest. Promoter holding stable [cite:]

Macro Context

Indian animal feed market projected to grow, driven by rising protein demand.

Order Book / Expansion

Secured order worth Rs 47.52 crore from an existing valued customer.

Cash Flow Quality

Negative free cash flow of ₹-10.62 Cr [cite:]

3–6 Month Outlook

Need to see consistent order execution and positive cash flow. Until then, it's a show-me story.

Primary Thesis Risk

Inability to convert sales into free cash flow will kill the story.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

5.15%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

6.91%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

3.40%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Ajooni Biotech Ltd Valuation Check

Poor

Price to Earnings (P/E)

20.51x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

18.96x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

26.89%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

50.00%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

23.41%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

23.40%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

57.50%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

55.56%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.10x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

14.63x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-10.62 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Ajooni Biotech Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of AJOONI across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Robust Profit Growth (50.00%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (23.41%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (23.40% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Excellent EPS Growth (57.50% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (55.56% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.10)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (14.63x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

6 factors identified

Below-Average Return on Equity (5.15%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (6.91%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (3.40%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Negative Free Cash Flow (₹-10.62 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (26.89%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Ajooni Biotech Ltd vs Animal Feed Peers

Peer Comparison - Animal Feed

Compare Ajooni Biotech Ltd with 7 other companies in the same sector

8 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
51.9/100
4
₹81.64
20.5
Average
5.15%
Poor
6.91%
Poor
0.1
Excellent
55.56%
Excellent
23.40%
Excellent
0.00%
32.8/100
593
₹11708.23
26.9
Average
17.68%
Good
16.59%
Good
1.2
Average
6.68%
Good
6.14%
Good
1.81%
64.8/100
1297
₹10813.08
17.5
Average
19.53%
Good
23.99%
Excellent
0.0
Excellent
8.20%
Good
6.40%
Good
1.13%
Kse Ltd...
KSE519421
59.1/100
2329
₹772.00
6.1
Average
33.98%
Excellent
42.92%
Excellent
0.1
Excellent
36.23%
Excellent
2.92%
Average
3.32%
51.1/100
23
₹770.99
16.3
Average
11.10%
Average
11.59%
Average
1.4
Average
32.54%
Excellent
12.88%
Good
0.00%
49.2/100
212
₹111.78
20.4
Average
16.79%
Good
16.45%
Good
0.9
Good
63.01%
Excellent
24.07%
Excellent
0.00%
33.9/100
9
₹111.27
32.0
Average
8.28%
Poor
11.38%
Average
0.6
Good
0.00%
42.8/100
37
₹88.29
23.1
Average
11.24%
Average
13.05%
Average
0.2
Excellent
38.94%
Excellent
1.03%
Average
0.00%

Ajooni Biotech Ltd PE Ratio History

Historical price-to-earnings ratio for AJOONI — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20240.25₹7.7731.1x
FY 20231.51₹5.643.7x
FY 20220.16₹5.5133.8x
FY 20210.06₹11.13193.4x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Ajooni Biotech Ltd Quarterly Performance

Latest quarterly metrics for AJOONI — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

23.41%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

50.00%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

23.40%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

55.56%

Compounded annual net profit growth over 5 years

Ajooni Biotech Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for AJOONI — calculated from daily price history

47RSI 14
Neutral — RSI 47

Momentum is balanced — neither overbought nor oversold.

SMA 50
4
▼ Price below SMA 50 — Short-term bearish
SMA 200
5
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
293K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Ajooni Biotech Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Ajooni Biotech Ltd (AJOONI) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Ajooni Biotech Ltd

About AJOONI (Ajooni Biotech Ltd)

Ajooni Biotech Ltd is a pioneering force in the Indian animal feed industry, dedicated to enhancing livestock health and productivity through innovative and nutritionally superior ...feed solutions. With a strong commitment to quality and sustainability, Ajooni Biotech formulates specialized feed products tailored to meet the unique dietary needs of various livestock species. They meticulously select high-quality ingredients, ensuring optimal nutrient content and digestibility to support healthy growth, efficient milk production, and overall well-being in animals. Their dedication extends beyond just production as they strive to create environmentally responsible practices. The company’s diverse product range includes premium cattle feed pellets crafted with precision, nutritious supplements enriched with essential vitamins and minerals, and specialized feed options for other livestock. Ajooni Biotech continually invests in research and development, collaborating with animal nutrition experts to stay at the forefront of industry advancements. This commitment allows them to refine existing formulas and introduce novel feed solutions that address specific challenges faced by farmers and livestock owners. It is also their desire to become more well known. Ajooni Biotech operates with a deep understanding of the crucial role animal feed plays in the overall livestock ecosystem and the livelihood of farmers. They prioritize building strong relationships with their customers, offering expert guidance and support to optimize feeding practices. Through its unwavering focus on quality, innovation, and customer service, Ajooni Biotech is dedicated to empowering livestock farmers and contributing to a more sustainable and prosperous animal agriculture sector. The goal is to keep livestock healthy through high quality and specialized feeds.

Company Details

Symbol:AJOONI
Industry:Animal Feed
Sector:Animal Feed

Key Leadership

Mr. Jasjot Singh
Chairman, CFO & MD
Mr. Gursimran Singh
CEO & Whole Time Director
Ms. Swati Vijan
Company Secretary & Compliance Officer

AJOONI Share Price: Frequently Asked Questions

What is the current share price of Ajooni Biotech Ltd?

Ajooni Biotech Ltd (AJOONI) trades at ₹3.81 on NSE. Market cap ₹81.64 (Cr). Educational data only.

What is the P/E ratio of Ajooni Biotech Ltd?

Ajooni Biotech Ltd has a P/E of 20.51x vs industry average 18.96x.

What is the Bull Run score for Ajooni Biotech Ltd?

Ajooni Biotech Ltd has a Bull Run score of 51.9/100 based on 25+ financial parameters.

Does Ajooni Biotech Ltd pay dividends?

Ajooni Biotech Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Ajooni Biotech Ltd?

Ajooni Biotech Ltd has ROE of 5.15%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Ajooni Biotech Ltd?

Ajooni Biotech Ltd has debt-to-equity of 0.10.

Is Ajooni Biotech Ltd a good investment?

Bull Run gives Ajooni Biotech Ltd a score of 51.9/100. This is not investment advice — consult a SEBI-registered advisor.